80
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Umbilical cord blood-selected CD133+ cells exhibit vasculogenic functionality in vitro and in vivo

, , , , , , , , , , & show all
Pages 67-78 | Received 24 Nov 2008, Accepted 28 Aug 2009, Published online: 02 Nov 2009

References

  • Werner NKS, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. New Eng J Med 2005;353:1055–7.
  • Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593–600.
  • Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, . Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981–7.
  • Tepper OMCJ, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005;105: 1068–77.
  • Dzau VJGM, Pachori AS, Morello F, Melo LG. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005;46:7–18.
  • Finney MR, Greco NJ, Haynesworth SE, Martin JM, Hedrick DP, Swan JZ, . Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol Blood Marrow Transplant 2006;12: 585–93.
  • Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, DeBondt P, . Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005;112:178–83.
  • Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, . Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45–6.
  • Van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol 2003;31:659–72.
  • Wojakowski W, Tendera M, Mchalowska A, Majka M, Kucia M, Maslankiewicz K, . Mobilization of CD34/CXCR4 +, CD34/CD117+, c-met+stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110:3213–20.
  • Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Symes J, . Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996;75:487–501.
  • Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH, Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 2006;107:2705–12.
  • Jackson DE, Ward CM, Wang R, Newman PJ. The protein tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling. J Biol Chem 1997;272:6986–93.
  • Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, . Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210–21.
  • Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, . Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222–32.
  • Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, . Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199–209.
  • Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, . Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615–22.
  • Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, . Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1–7.
  • Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 2002;90:E89–93.
  • Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al.Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527–36.
  • Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, . Identification of a novel hierarchy of endothe-lial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752–60.
  • Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, . A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004;200:123–35.
  • Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, . Myocardial homing and neovasculariza-tion by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 2006;40:455–64.
  • Behm CZ, Kaufmann BA, Carr C, Lankford M, Sanders JM, Rose CE, . Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008;117:2902–11.
  • Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 2003;107:3133–40.
  • Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, . Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation 2004;109:1594–602.
  • Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothe-lial progenitor cells. EMBO J 1999;18:3964–72.
  • Henrich D, Hahn P, Wahl M, Wilhelm K, Dernbach E, Dimmeler S, Marzi I. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor 165. Shock 2004;21:13––6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.